We are live on
!
Find out more
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Axsome Therapeutics
AXSM
$8.5B
| $659K | ﹤0.01% |
3,901
+636
| +19% | +$110K |
2024 Q3
6 quarters
|
|
902
Abercrombie & Fitch
ANF
$6.35B
| $657K | ﹤0.01% |
7,188
+1,245
| +21% | +$121K |
2023 Q4
9 quarters
|
|
903
Pegasystems
PEGA
$5.56B
| $657K | ﹤0.01% |
15,427
+3,193
| +26% | +$148K |
2023 Q1
12 quarters
|
|
904
FTI Consulting
FCN
$3.87B
| $655K | ﹤0.01% |
3,703
+892
| +32% | +$152K |
2020 Q2
23 quarters
|
|
905
Sonoco
SON
$4.86B
| $647K | ﹤0.01% |
11,957
+2,778
| +30% | +$143K |
2020 Q2
23 quarters
|
|
906
Selective Insurance
SIGI
$5.14B
| $644K | ﹤0.01% |
8,548
+1,149
| +16% | +$94K |
2020 Q2
23 quarters
|
|
907
iShares MSCI ACWI ETF
ACWI
$32.8B
| $644K | ﹤0.01% |
4,655
+2,662
| +134% | +$383K |
2025 Q4
1 quarter
|
|
908
Belden
BDC
$4.07B
| $641K | ﹤0.01% |
5,578
+792
| +17% | +$99.8K |
2020 Q4
21 quarters
|
|
909
Shift4
FOUR
$3B
| $640K | ﹤0.01% |
14,646
+1,819
| +14% | +$100K |
2021 Q2
19 quarters
|
|
910
AutoNation
AN
$5.06B
| $640K | ﹤0.01% |
3,277
+682
| +26% | +$138K |
2020 Q3
22 quarters
|
|
911
Sanmina
SANM
$10.4B
| $639K | ﹤0.01% |
4,932
+615
| +14% | +$90.4K |
2023 Q1
12 quarters
|
|
912
SiteOne Landscape Supply
SITE
$3.9B
| $638K | ﹤0.01% |
4,790
+990
| +26% | +$140K |
2021 Q2
19 quarters
|
|
913
Avantor
AVTR
$10.6B
| $636K | ﹤0.01% |
81,161
+18,943
| +30% | +$186K |
2020 Q2
23 quarters
|
|
914
Transocean
RIG
$6.23B
| $636K | ﹤0.01% |
95,948
+13,839
| +17% | +$77.9K |
2024 Q2
7 quarters
|
|
915
Uranium Energy
UEC
$3.82B
| $635K | ﹤0.01% |
47,071
+7,403
| +19% | +$114K |
2021 Q2
19 quarters
|
|
916
PBF Energy
PBF
$10.6B
| $635K | ﹤0.01% |
13,327
+520
| +4% | +$19.5K |
2022 Q4
13 quarters
|
|
917
Novanta
NOVT
$5.3B
| $633K | ﹤0.01% |
5,360
+741
| +16% | +$97.2K |
2021 Q2
19 quarters
|
|
918
Archrock
AROC
$5.22B
| $628K | ﹤0.01% |
18,038
+3,207
| +22% | +$102K |
2024 Q3
6 quarters
|
|
919
JBT Marel
JBTM
$5.43B
| $626K | ﹤0.01% |
4,896
+775
| +19% | +$117K |
2024 Q3
6 quarters
|
|
920
Vontier
VNT
$4.38B
| $624K | ﹤0.01% |
17,601
+3,854
| +28% | +$148K |
2021 Q1
20 quarters
|
|
921
Qiagen
QGEN
$9.41B
| $620K | ﹤0.01% |
15,491
+4,991
| +48% | +$236K |
2022 Q4
13 quarters
|
|
922
Bio-Rad Laboratories Class A
BIO
$9.69B
| $620K | ﹤0.01% |
2,225
+527
| +31% | +$152K |
2020 Q2
23 quarters
|
|
923
Cousins Properties
CUZ
$4.42B
| $619K | ﹤0.01% |
27,441
+2,963
| +12% | +$71.8K |
2020 Q2
23 quarters
|
|
924
DELISTED
Clearwater Analytics
CWAN
| $618K | ﹤0.01% |
26,141
+4,122
| +19% | +$97.5K |
2024 Q3
6 quarters
|
|
925
Lumen Technologies, Inc. Common Stock
LUMN
$4.69B
| $618K | ﹤0.01% |
88,903
+12,992
| +17% | +$98.3K |
2021 Q1
20 quarters
|
|
Similar funds
NMO
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.